Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Immunology is Scopus-indexed (Q1, CiteScore 11.3), WoS SCIE, DOAJ. Published by Frontiers Media SA.
Checked against the index lists dated .
ISSN 1664-3224Verify ISSN ↗
Publisher: Frontiers Media SA
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 33 / 234 | 86th | Q1 |
| Immunology | 37 / 243 | 84th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q1, CiteScore 11.3.
Frontiers in Immunology is Q1 in Immunology and Allergy (rank 33 of 234) and Q1 in Immunology (rank 37 of 243), by CiteScore 2025.
Frontiers in Immunology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 11.3, which places it in quartile Q1 at the 86th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.964, quartile Q1, with an H-index of 294.
The publisher lists an article processing charge of about US$3,801 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Frontiers in Immunology is published by Frontiers Media SA. Its ISSN is 1664-3224.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Frontiers in Immunology has an h-index of 356 and a 2-year mean of 5.42 citations per paper (OpenAlex). Its Scopus CiteScore is 11.3, quartile Q1. On 2-year citations it ranks #38 of 231 Scopus journals in Immunology and Allergy.
Frontiers in Immunology published 7,027 papers in 2025; its busiest recent year was 2022 with 8,221. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2026), authors are most often from China (55.1%), United States (15.2%) and United Kingdom (2.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 102 retracted papers are recorded (1.8 per 1,000 papers). The Problematic Paper Screener flags 5 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.